Evolus (EOLS) Cash & Equivalents (2018 - 2026)

Evolus' Cash & Equivalents history runs 9 years deep, the most recent figure standing at $49.8 million for Q1 2026.

• Quarterly Cash & Equivalents fell 26.66% year-over-year to $49.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.8 million (down 26.66% YoY) and the FY2025 annual result came in at $53.8 million, down 38.1% from the prior year.
• Cash & Equivalents was $49.8 million for Q1 2026 at Evolus, down from $53.8 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $106.7 million in Q1 2022 and bottomed at $31.5 million in Q1 2023.
• A 5-year average of $66.2 million and a median of $62.8 million in 2023 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents jumped 381.13% — and 2023, when it tumbled 70.5%.
• Evolus' Cash & Equivalents stood at $53.9 million in 2022, then grew by 16.53% to $62.8 million in 2023, then jumped by 38.37% to $87.0 million in 2024, then slumped by 38.1% to $53.8 million in 2025, then slipped by 7.49% to $49.8 million in 2026.
• Business Quant data shows EOLS's Cash & Equivalents at $49.8 million in Q1 2026, $53.8 million in Q4 2025, and $43.5 million in Q3 2025.